168 related articles for article (PubMed ID: 20545508)
1. Preparation and characterization of puerarin-dendrimer complexes as an ocular drug delivery system.
Yao W; Sun K; Mu H; Liang N; Liu Y; Yao C; Liang R; Wang A
Drug Dev Ind Pharm; 2010 Sep; 36(9):1027-35. PubMed ID: 20545508
[TBL] [Abstract][Full Text] [Related]
2. Effects of poly(amidoamine) dendrimers on ocular absorption of puerarin using microdialysis.
Yao C; Wang W; Zhou X; Qu T; Mu H; Liang R; Wang A; Sun K
J Ocul Pharmacol Ther; 2011 Dec; 27(6):565-9. PubMed ID: 21895496
[TBL] [Abstract][Full Text] [Related]
3. Effect of poly(amidoamine) dendrimers on corneal penetration of puerarin.
Yao WJ; Sun KX; Liu Y; Liang N; Mu HJ; Yao C; Liang RC; Wang AP
Biol Pharm Bull; 2010; 33(8):1371-7. PubMed ID: 20686234
[TBL] [Abstract][Full Text] [Related]
4. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin.
Gu L; Wu Zh; Qi X; He H; Ma X; Chou X; Wen X; Zhang M; Jiao F
Pharm Dev Technol; 2013; 18(5):1051-7. PubMed ID: 22303809
[TBL] [Abstract][Full Text] [Related]
5. Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin.
Durairaj C; Kadam RS; Chandler JW; Hutcherson SL; Kompella UB
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5804-16. PubMed ID: 20484584
[TBL] [Abstract][Full Text] [Related]
6. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.
Vandamme TF; Brobeck L
J Control Release; 2005 Jan; 102(1):23-38. PubMed ID: 15653131
[TBL] [Abstract][Full Text] [Related]
7. Determination of puerarin in rabbit aqueous humor by liquid chromatography tandem mass spectrometry using microdialysis sampling after topical administration of puerarin PAMAM dendrimer complex.
Wang WY; Yao C; Shao YF; Mu HJ; Sun KX
J Pharm Biomed Anal; 2011 Dec; 56(4):825-9. PubMed ID: 21831555
[TBL] [Abstract][Full Text] [Related]
8. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
[TBL] [Abstract][Full Text] [Related]
9. Promoting effect of borneol on the permeability of puerarin eye drops and timolol maleate eye drops through the cornea in vitro.
Wu CJ; Huang QW; Qi HY; Guo P; Hou SX
Pharmazie; 2006 Sep; 61(9):783-8. PubMed ID: 17020156
[TBL] [Abstract][Full Text] [Related]
10. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
11. [New systems of drug administration through a topical ocular administration approach].
Herrero Vanrell R
Arch Soc Esp Oftalmol; 2001 Mar; 76(3):143-4. PubMed ID: 11283777
[No Abstract] [Full Text] [Related]
12. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of puerarin liposome and its oral absorption in rat].
Gu YZ; Zhou W; Zhai GX
Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848
[TBL] [Abstract][Full Text] [Related]
14. [Corneal penetration of PAMAM dendrimers-coated puerarin liposomes].
Liu Y; Sun K; Yao W; Liang N; Mu H; Liang R; Yao C
Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(1):30-4. PubMed ID: 20349711
[TBL] [Abstract][Full Text] [Related]
15. [Preparation and lacrimal pharmacokinetics of eye drops of puerarin liposomes in rabbit tears].
Deng Y; Xu J; Li X
Zhongguo Zhong Yao Za Zhi; 2010 Feb; 35(3):301-4. PubMed ID: 20422993
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities.
Zhao C; Wang Y; Su Y; Zhang H; Ding L; Yan X; Zhao D; Shao N; Ye X; Cheng Y
Int J Pharm; 2011 Dec; 421(2):301-9. PubMed ID: 22001794
[TBL] [Abstract][Full Text] [Related]
17. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
18. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
Li X; Nie SF; Kong J; Li N; Ju CY; Pan WS
Int J Pharm; 2008 Nov; 363(1-2):177-82. PubMed ID: 18706987
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
